In addition, dual blockade of NKG2A and LIR-1 improves the cytotoxicity of KIR-NK cells and leads to significant killing of AML or acute lymphocytic leukemia cells [39]; thus, removing the inhibition of NK cells is required for cancer cell lysis. The gene discussed is KLRC1; the disease is cancer.